NCT02442557 Safety and Dose-finding Study of DC-TAB in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02440516 Standardized Ambulatory Neurorehabilitation Program for Patients With Multiple Sclerosis Status COMPLETED Phase NA
NCT02440126 Longitudinal Analysis And Sample Collection To Evaluate PML Risk Host Markers for PML Risk Host Markers for PML Risk Status COMPLETED Phase N/A
NCT02427997 VR-treadmill Combined Intervention for Enhancing Mobility and Cognitive Function in Patients With Multiple Sclerosis Status COMPLETED Phase NA
NCT02425644 Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis Status COMPLETED Phase PHASE3
NCT02421731 Robot-assisted Gait Training on Mobility in Severely Disabled Multiple Sclerosis Patients Status COMPLETED Phase NA
NCT02419638 Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting MS Status WITHDRAWN Phase N/A
NCT02418897 Role of Neuromuscular Junction Function in Motor Fatigue in Multiple Sclerosis Status COMPLETED Phase N/A
NCT02410278 Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving Tecfidera Status COMPLETED Phase PHASE4
NCT02408380 Analysis of a Biomarker Signature in Patients With Multiple Sclerosis (MS) Treated With Gilenya (FTY720) Status UNKNOWN Phase N/A
NCT02408367 Intensity Depended Impacts on Cognitive Functions in Persons With Multiple Sclerosis - a Pilot Study Status UNKNOWN Phase N/A
NCT02403570 Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis Status COMPLETED Phase N/A